Newsletter - Banner
David Buckeridge is one of 47 Canadian researchers chosen to contribute to the global response
March 9, 2020
Source: McGill Reporter. McGillians David Buckeridge and Amine Kamen are among the 47 researchers across Canada who have been chosen to contribute to the global response to the COVID-19 outbreak as part of the Canadian 2019 Novel COVID-19 Rapid Research Funding Opportunity. A senior scientist at the Research Institute of the McGill University Health Centre and professor in the Department of Epidemiology, Biostatistics and Occupational Health at McGill University, Dr. Buckeridge focuses on public health informatics. In particular, he is interested in automated surveillance to detect disease outbreaks and to guide public health interventions. Dr. Buckeridge will receive $500,000 over the next two years for his project, “Using Online News Media to Assess Community and Public Health Responses to COVID-19.” Read more.
CBC | These Quebec professors are trying to develop a coronavirus vaccine
Success in a demanding AI funding competition
Dr. David Buckeridge’s project with Dr. Nigel Collier, University of Cambridge (UK), was also supported recently in a demanding AI funding competition. Their submission, “EPI-AI: Automated Understanding and Alerting of Disease Outbreaks from Global News Media,” will be funded by the Social Sciences and Humanities Research Council, which announced the results of the competition for the Canada-UK Artificial Intelligence (AI) Initiative in February. This initiative supports the development of collaborations between researchers in Canada and in the UK. Each winning project will receive up to $173,333 per year up to three years, for a total of $520,000 CAD per project. Read more.